Eve & Co Announces Product Release
12 December 2018 - 12:36AM
Eve & Co Incorporated (TSX-V: EVE; OTCQB: EEVVF) (“Eve &
Co” or the “Company”) is pleased to announce that its initial
product line is now available for purchase on the Cannabis NL
website, which is operated by a division of the Newfoundland
Labrador Liquor Corporation responsible for cannabis distribution
across Newfoundland and Labrador.
“Our first release consists of a selection of
clones in a variety of strains with high THC, medium THC and 1:1
THC/CBD levels” explained Melinda Rombouts, CEO of Eve & Co.
“We will be one of the first licensed producers of cannabis in
Canada to offer clones to the Canadian recreational market.”
The Company believes it is uniquely positioned
among its peers to offer a selection of clones given its
management’s prior experience in the non-cannabis greenhouse
industry and related production and sale of high-quality plants.
Drawing on this experience, the Company will be using a unique
solution for clone shipping and packaging to ensure its offerings
are competitive.
ABOUT EVE & CO INCORPORATED
Eve & Co, through its wholly-owned
subsidiary Natural MedCo Ltd., holds cultivation and processing
licenses under the Cannabis Act (Canada) for the production and
sale of various cannabis products, including dried cannabis,
cannabis plants and cannabis oil. Natural MedCo Ltd. was Canada’s
first female founded licensed producer of medicinal marijuana, and
received its cultivation license from Health Canada in 2016.
Eve & Co is led by a team of agricultural
experts and has a licenced 220,000 sq. ft. scalable greenhouse
production facility located in Middlesex County, Ontario with 32
acres of adjacent land for future expansion. Eve & Co has
broken ground on an additional 780,000 sq. ft. expansion, bringing
Eve & Co’s total anticipated greenhouse capacity to 1,000,000
sq. ft.
The Company’s website can be visited at
www.evecannabis.ca.
Neither the TSX Venture Exchange nor its
regulation services provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release.
Certain statements in this press release
constitute forward-looking information. All statements other than
statements of historical fact contained in this press release,
including, without limitation, those regarding the Company’s
expansion plans, future, strategy, plans, objectives, goals and
targets, and any statements preceded by, followed by or that
include the words “believe”, “expect”, “aim”, “intend”, “plan”,
“continue”, “will”, “may”, “would”, “anticipate”, “estimate”,
“forecast”, “predict”, “project”, “seek”, “should” or similar
expressions or the negative thereof, are forward-looking
statements. These statements are not historical facts but instead
represent only the Company’s expectations, estimates and
projections regarding future events. These statements are not
guarantees of future performance and involve assumptions, risks and
uncertainties that are difficult to predict, including those
described in the Company’s management’s discussion and analysis for
the three and nine months ended July 31, 2018 which is available on
the Company’s SEDAR profile. Therefore, actual results may differ
materially from what is expressed, implied or forecasted in such
forward-looking statements. The forward-looking information and
forward-looking statements included in this news release are made
as of the date of this news release the Company does not undertake
an obligation to publicly update such forward-looking information
or forward-looking information to reflect new information,
subsequent events or otherwise unless required by applicable
securities law.
For further information, please
contact:
Melinda RomboutsPresident and Chief Executive OfficerEve & Co
IncorporatedTelephone: (855) 628-6337 |
|
|
|
Landon RoeddingChief Financial OfficerEve & Co
IncorporatedTelephone: (647) 473-4947 |
|
Eve & (TSXV:EVE)
Historical Stock Chart
From Jun 2024 to Jul 2024
Eve & (TSXV:EVE)
Historical Stock Chart
From Jul 2023 to Jul 2024